Skip to main content
v2026.11,986 entries · CC-BY 4.0
LAC HealthSponsored

Shop pasi score supplies

  • FDA registered
  • ISO 13485
  • BBB Accredited A+

Shop at LAC Health

PASI Score: Psoriasis Area and Severity Index Explained

How the PASI score is built, a worked hypothetical example, and why severity cutoffs differ between guidelines.

Written and maintained by CASRAI Editorial Board

Published

On this page

General reference for researchers and clinic or lab staff. This page is not medical advice and does not tell anyone how to score or treat their own skin.

Short answer

The Psoriasis Area and Severity Index (PASI) is a clinician-rated score from 0 to 72 that combines how much of the body psoriasis covers with how red, thick and scaly the plaques are. Higher means more severe. It needs no device, only a trained assessor, and it is the standard efficacy endpoint in psoriasis trials. Many guidelines treat a PASI above 10 as the line between mild and moderate-to-severe disease, but cutoffs vary by source.

What is PASI and what does it measure?

PASI is an index scale used to determine the severity of plaque psoriasis. Altmeyer’s Encyclopedia describes it as developed as a target for retinoid efficacy studies in chronic plaque psoriasis, and as the best-known, well-standardized index for the purpose. It scores four body regions separately, then adds them. It rates the skin only: it does not measure itch, pain, joint disease or the effect on daily life, which is why it is usually paired with other measures (see the comparison below).

How the PASI score is built

For each region the assessor grades three signs from 0 (absent) to 4 (very severe): erythema (redness), infiltration (plaque thickness) and desquamation (scaling). The three grades are added, multiplied by an area grade for that region, then multiplied by a regional weight. The four regional results are summed.

Region Weight
Head 0.1
Upper limbs 0.2
Trunk 0.3
Lower limbs 0.4

The area grade runs from 0 to 6: 0 = no involvement; 1 = under 10% of the region; 2 = 10-29%; 3 = 30-49%; 4 = 50-69%; 5 = 70-89%; 6 = 90-100%. Each region therefore contributes weight × (erythema + infiltration + desquamation) × area grade, and PASI is the sum of the four. The maximum is 72: each region at its ceiling gives 7.2 + 14.4 + 21.6 + 28.8.

Worked arithmetic (hypothetical, not a real patient)

Suppose a made-up assessment gives: head, signs 2+2+2 = 6, area grade 1, so 0.1 × 6 × 1 = 0.6. Upper limbs clear, so 0. Trunk, signs 3+2+2 = 7, area grade 2, so 0.3 × 7 × 2 = 4.2. Lower limbs, signs 1+1+1 = 3, area grade 1, so 0.4 × 3 × 1 = 1.2. Total PASI = 0.6 + 0 + 4.2 + 1.2 = 6.0. The example shows two structural features: the weights make the lower limbs and trunk count far more than the head, and the area grade steps in bands, so small changes in coverage matter only when they cross a band boundary.

Interpreting the number: why cutoffs differ

No single universal severity scale exists, and sources draw the lines differently.

  • Rule of tens. Finlay’s 2005 rule classes psoriasis as currently severe if body surface area (BSA) is above 10%, PASI is above 10, or the Dermatology Life Quality Index (DLQI) is above 10. A 2022 letter in the British Journal of Dermatology notes it does not account for long-term severity.
  • European Delphi consensus (2011). Moderate-to-severe psoriasis is (BSA > 10 or PASI > 10) and DLQI > 10, so both a body-measure and a life-quality threshold must be met.
  • German S3 guideline, as cited by Altmeyer’s. PASI of 10 or below is mild and above 10 is moderate-to-severe, with the same split for BSA and DLQI. Mild disease can be reclassified upward for scalp, anogenital or nail involvement, or therapy resistance.

The reclassification rule exists because a score driven by area can understate disease at sensitive sites.

PASI compared with BSA and DLQI

Measure What it captures “Severe” threshold in the rule of tens
PASI Area plus redness, thickness and scaling, 0-72 Above 10
BSA Percentage of body surface affected Above 10%
DLQI Dermatology Life Quality Index, the impact on the patient Above 10

PASI and BSA are clinician-observed signs; DLQI reflects impact on the patient, so the measures can disagree. That is a design difference, not an error in either.

Relative and absolute use: PASI 75 versus thresholds

PASI 75 means a 75% reduction from the patient’s own baseline PASI; PASI 90 and 100 are the stricter equivalents. Relative endpoints are used to monitor systemic therapy and in trials. Their weakness is dependence on the baseline: Geale and Schmitt-Egenolf note that patients with high pre-treatment activity may not reach acceptable control despite achieving a relative improvement endpoint. They argue for separating severity from symptom control and propose control criteria that exclude relative endpoints such as PASI 75, in part because the baseline is often unknown. German guidance uses absolute thresholds of PASI 3 or below (or DLQI 2 or below) to define successful treatment.

Where it matters for labs and clinics

  • PASI is assigned by a trained clinician from examination. No instrument or consumable is involved, so there is nothing to calibrate or stock.
  • Because it is rater-dependent, studies using it rely on assessor training and agreement; see choosing an inter-rater reliability coefficient and criterion validity for how such scales are evaluated.
  • Staff reading trial or registry reports should note whether results are reported as absolute scores or as PASI 75/90 responses, since these answer different questions.
  • For other clinical scoring tools, see the Modified Early Warning Score and the CTCAE grading scale. For the specialty context, see what is dermatology.

Common misunderstandings

  • “PASI is the same as BSA.” BSA is only coverage; PASI also grades redness, thickness and scaling and weights regions.
  • “A score under 10 means psoriasis is not a problem.” Guidelines allow mild disease to be reclassified upward for sensitive sites or therapy resistance, and a clinician’s judgement goes beyond the number.
  • “PASI 75 means a score of 75.” It means a 75% improvement from baseline. The scale tops out at 72.
  • “There is a single official cutoff.” The rule of tens, the European Delphi consensus and national guidelines differ.

PASI calculators, sheets and PDFs

CASRAI offers no calculator or scoring sheet, and this page is not a self-scoring guide. The formula above is shown so readers can understand published results; scoring an actual patient belongs to a trained clinician.

FAQ

What is the Psoriasis Area Severity Index (PASI)?

A clinician-rated 0-72 index combining the extent of psoriasis in four body regions with the redness, thickness and scaling of plaques.

What is PASI?

The common abbreviation for the index described here; it is the standard severity endpoint in psoriasis trials.

How severe is psoriasis?

It depends on the source. Under the rule of tens, a PASI, BSA or DLQI above 10 marks currently severe disease; the European Delphi consensus requires a DLQI above 10 in addition to BSA or PASI above 10. Severity is a clinical judgement that also considers site and impact.

How often should you shower with psoriasis?

That is an individual care question and outside what a scoring-scale reference can answer. Ask the treating clinician.

Sources

  • Altmeyer’s Encyclopedia, “PASI,” altmeyers.org/en/dermatology/pasi-129394, read 2026-11-07.
  • Geale K, Schmitt-Egenolf M. Severity of psoriasis: time to disentangle severity from symptom control. Br J Dermatol 2022;186(6):1033-1034. doi:10.1111/bjd.21023, PMC9321554, read 2026-11-07.

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Ask CASRAI · free to try

Ask about PASI Score: Psoriasis Area and Severity Index Explained

2 free questions a day, no account.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →